Cynata Receives $1.749m R&D Tax Incentive Refund
Filed with ASX · · 1 page · English
Cynata Therapeutics Limited on 6ix
In the deck
Story so far
Earlier from Cynata Therapeutics
- Activities Report & Appendix 4C
- Efficacy for CYP MSC Technology in Preclinical Asthma Study
- UK Regulatory Authority Approves Cynata GvHD Clinical Trial
- CYP Determines not to proceed with Regience Investment Offer
- CYP & FUJIFILM Sign Non-Binding Terms Sheet
Later from Cynata Therapeutics
- Cynata Files Further Patent Application
- Cynata Receives NHS HRA Approval for Clinical Study
- Cynatas Clinical Study Approved in Austrralia
- Cynata & FUJIFILM Sign Strategic Partnership Agreement
- Cynata Successfully Completes Capital Raising
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics